Menu
About Us
Company Overview
Our Values
Board of Directors
Team
Scientific Advisers
Clinical Advisers
Corporate Directory
Corporate Governance
Pipeline
Clinical Trial
Investor Centre
Welcome
Investor Fact Sheet
ASX Announcements
Reports
Annual Reports
Half Yearly Reports
Quarterly Reports
Top 20 Shareholders
Research Reports
Shareholder Services
Investor FAQs
US Shareholders
Communication
In the News
Presentations
Contact Us
Contact Us
Email Alerts
In the news
Recent Posts
Amplia receives R&D Tax Rebate
Key chemical form patents in Europe and Japan
Fourth partial response confirmed in ACCENT trial
ASX Briefs podcast | Interview with Dr Chris Burns
Three confirmed partial responses observed in Phase 2a ACCENT trial
JustStocks Feature Article and Video Interview with Amplia CEO Dr Chris Burns
Categories
Archive
Company News
Investor Newsletters
Videos
12 Aug 2024
Amplia receives R&D Tax Rebate
Read More
07 Aug 2024
Key chemical form patents in Europe and Japan
Read More
06 Aug 2024
Fourth partial response confirmed in ACCENT trial
Read More
02 Aug 2024
ASX Briefs podcast | Interview with Dr Chris Burns
Read More
1